PALO ALTO, CA – A groundbreaking new artificial intelligence diagnostic system, 'Medi-Profit 3000,' has been unveiled, promising to revolutionize healthcare by identifying patients whose treatment costs are projected to outweigh their long-term financial contributions to the system. Developers say the AI’s sophisticated algorithms can pinpoint individuals who are, from a purely fiscal perspective, 'insufficiently profitable.'

“This isn’t about denying care; it’s about optimizing it,” explained Dr. Evelyn Thorne, lead AI ethicist for OmniCorp Health Solutions, at a press conference. “The Medi-Profit 3000 provides invaluable data, allowing providers to focus resources where they can generate the most sustainable returns. Think of it as proactive fiscal wellness.” Dr. Thorne clarified that the system does not explicitly recommend withholding treatment, but rather “flags” patients for “alternative care pathways” and “personalized financial counseling.”

Industry analysts are already praising the innovation. “For too long, healthcare has been burdened by the quaint notion that every life has intrinsic value,” stated financial pundit Miles Sterling. “This AI finally brings the cold, hard logic of the market into the examination room. It’s not just a diagnostic tool; it’s a portfolio manager for human capital.”

Early trials have shown the Medi-Profit 3000 to be remarkably efficient at identifying individuals over 65, those with pre-existing conditions, and anyone who has ever expressed concern about their medical bills. Critics, however, have raised concerns about the AI's tendency to classify children as 'long-term liabilities with unpredictable ROI.'